Globe Life (GL) Q4 2024 earnings summary

Executive summary

• Net income for Q4 2024 was $255 million ($3.01 per share), down from $275 million a year ago, while net operating income rose 12% to $266 million ($3.14 per share).

• Full-year 2024 net income was $11.94 per diluted share, up from $10.07; net operating income was $12.37 per share, up from $10.65.

• Return on equity (ROE) was 21.7% on a GAAP basis and 15.1% excluding AOCI; book value per share excluding AOCI rose 13% year-over-year.

• Net income increased 10% and net operating income increased 8% year-over-year.

• Total premium income grew 4.7% in 2024, outpacing 2023's 3.4% growth, reflecting business resiliency post-inflation.

Financial highlights

• Life insurance premium revenue increased 4% to $823 million; life underwriting margin up 10% to $336 million.

• Health insurance premium revenue grew 7% to $358 million, but health underwriting margin declined 6% to $91 million due to higher claim costs.

• Net investment income rose 4% to $282 million; excess investment income was $38 million, up $3 million year-over-year.

• Q4 insurance underwriting income rose 16% to $3.99 per share; excess investment income per share up 18% to $0.45.

• Administrative expenses ratio increased to 7.7% of premium from 6.8% year-over-year.

Outlook and guidance

• 2025 life premium revenue expected to grow 4.5%-5%; health premium revenue projected to rise 7.5%-8.5%.

• Life underwriting margin as a percent of premium guided to 40%-42%; health underwriting margin to 25%-27%.

• Net operating earnings per diluted share for 2025 estimated at $13.45-$14.05, 11% growth at midpoint.

• Share repurchases expected to remain primary use of excess cash flow, with $600-$650 million targeted for 2025.